Ralf Lotz
-
- Diabetes Treatment and Management 2
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 3
-
- Neuropeptides and Animal Physiology 2
- Pharmacology top 10%
- Pharmaceutical Science top 10%
-
- Receptor Mechanisms and Signaling 6
- Phosphodiesterase function and regulation 2
-
- Analytical Chemistry and Chromatography 2
-
- Computational Drug Discovery Methods 2
-
- Pharmacological Effects and Assays 2
Ralf Lotz
19 papers receiving 936 citations
Peers
Comparison fields: 5 of 93
- Endocrinology, Diabetes and Metabolism 185
- Oncology 270
- Cellular and Molecular Neuroscience 122
- Pharmacology 54
- Pharmaceutical Science 37
Countries citing papers authored by Ralf Lotz
This map shows the geographic impact of Ralf Lotz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Lotz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Lotz more than expected).
Fields of papers citing papers by Ralf Lotz
This network shows the impact of papers produced by Ralf Lotz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Lotz. The network helps show where Ralf Lotz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ralf Lotz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2020 | 4 | |
| 3 | 2020 | 9 | |
| 4 | 2019 | 44 | |
| 5 | 2019 | 138 | |
| 6 | 2019 | 12 | |
| 7 | 2015 | 8 | |
| 8 | 2015 | 6 | |
| 9 | 2015 | 2 | |
| 10 | 2010 | 64 | |
| 11 | 2010 | 0 | |
| 12 | 2009 | 202 | |
| 13 | 2008 | 28 | |
| 14 | 2007 | 230 | |
| 15 | 1998 | 10 | |
| 16 | 1997 | 55 | |
| 17 | Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance. | 1997 | 33 |
| 18 | 1997 | 5 | |
| 19 | 1995 | 98 | |
| 20 | [Analytical studies of the blood circulation for diagnosis and therapy of autonomic disorders]. | 1954 | 1 |
About Ralf Lotz
Ralf Lotz is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Animal Science and Zoology, having authored 20 papers that have together received 951 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Drug Transport and Resistance Mechanisms (3 papers), Analytical Chemistry and Chromatography (2 papers), Computational Drug Discovery Methods (2 papers), Diabetes Treatment and Management (2 papers), Neuropeptides and Animal Physiology (2 papers), Phosphodiesterase function and regulation (2 papers) and Pharmacological Effects and Assays (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (185 citations), Oncology (270 citations) and Cellular and Molecular Neuroscience (122 citations). Ralf Lotz has collaborated with scholars based in Germany, South Korea and Japan. Frequent co-authors include Peter Sieger, Leo Thomas, Brian D. Guth, Herbert Nar, Frank Himmelsbach, Michael Mark, Elke Langkopf, Moh Tadayyon, Matthias Eckhardt and Armin Heckel. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.